Table 1 |
||||||
|
Cohort studies of smokeless tobacco and cancer |
||||||
|
Study |
Country |
Follow-up period |
Baseline population |
Exposurea |
Referenceb |
Cancers studied (cases)c |
|
|
||||||
|
Lutheran Brotherhood cohortd |
USA |
1966 to 1986 |
17,633 white men aged 35+ years |
ST |
Hsing et al. 1990 [11] |
Prostate (149) |
|
Kneller et al. 1991 [12] |
Stomach (75) |
|||||
|
Zheng et al. 1993 [13] |
Pancreas (57) |
|||||
|
US Veterans cohorte |
USA |
1954/57 to 1980 |
248,046 US veterans aged 31–84 years, over 99.5% men |
ST |
Hsing et al. 1991 [15] |
Prostate (4,607) |
|
Heineman et al. 1992 [16] |
Multiple myeloma (582)f |
|||||
|
Zahm et al. 1992 [17] |
Soft tissue sarcoma (119), pharynx (55), buccal cavity (74) |
|||||
|
Heineman et al. 1995 [18] |
Colon (3,812), rectum (1,100) |
|||||
|
Iowa cohort |
USA |
1986/89 to 1995 |
1,572 men aged 40+ years, controls in a case-control study |
ST |
Putnam et al. 2000 [20] |
Prostate (101)f |
|
NHANES I follow-up cohortg |
USA |
1971/75 to 2002 |
14,407 adults aged 25–74 yearsh |
ST |
Accort et al. 2002 [21] |
All, lungi |
|
Accort et al. 2005 [22] |
All, lung, breast, digestive, oral, prostatef, i |
|||||
|
CPS-Ij |
USA |
1959 to 1972 |
77,407 never smoking men aged 30+ years from 25 states |
ST |
Henley et al. 2005 [23] |
All (2,332), oral (13), digestive (913), lung (134), genitourinary (559) |
|
CPS-IIk |
USA |
1982 to 2000 |
114,809 never smoking men aged 30+ years nationwide |
STl |
Henley et al. 2005 [23] |
All (6,140), oral (46), digestive (1,999), lung (400), genitourinary (1,709), haematopoietic (923) |
|
1982 to 1996 |
467,788 men aged 30+ years nationwide |
ST |
Chao et al. 2002 [24] |
Stomach (996) |
||
|
Norway cohortsm |
Norway |
1966 to 2001 |
10,136 men from two cohorts, a sample of the 1960 census and relatives of Norwegian migrants to the USA |
Snuff |
Boffetta et al. 2005 [26] |
Oral (34), oesophagus (27), stomach (217), pancreas (105), lung (343), kidney (88), bladder (239)n |
|
Swedish construction workers |
Sweden |
1974 to 1985 |
135,036 men |
Snuff |
Bolinder et al. 1994 [28] |
All (1,269), lung (204) |
|
1971 to 2000 |
337,311 men |
Odenbro et al. 2005 [29] |
Cutaneous squamous cell carcinoma (756)f |
|||
|
1971 to 2000 |
335,612 adults, over 99.3% men |
Fernberg et al. 2006 [30] |
Malignant lymphoma (1,514)f |
|||
|
1971 to 2004 |
336,381 men |
Fernberg et al. 2007 [31] |
Leukaemia (372), multiple myeloma (520)f |
|||
|
1978 to 2004 |
279,897 men |
Luo et al. 2007 [32] |
Oral (248), lung (2,198), pancreas (448)f |
|||
|
1971 to 2004 |
339,802 men |
Odenbro et al. 2007 [33] |
Melanoma (1,639)° |
|||
|
1971 to 2004 |
336,381 men |
Zendehdel et al. 2008 [34] |
Stomach (1,385), oesophagus (366)f |
|||
|
Uppsala County cohort |
Sweden |
1973/74 to 2002 |
9,976 men |
Snuff |
Roosaar et al. 2008 [35] |
All (1,572), smoking-related (493), oral (34)p |
|
|
||||||
|
a Only exposures for which results are available are shown. b Main references. Other references supplying limited data are indicated in footnotes. c Numbers of cases are totals for the sexes specified. Numbers of cases exposed to ST are shown in the tables presenting results by site. Cases are deaths, unless indicated. Oral is used as an abbreviation for oropharnyx. d Some limited additional results for the Lutheran Brotherhood cohort, based on follow-up to 1981, were reported earlier for cancers of the prostate, pancreas and oesophagus in IARC Monograph 37 in 1985 [14]. e Some limited additional results for the US Veterans cohort, based on follow-up from 1954 to 1969 were presented earlier for a range of cancers in an abstract by Winn et al. in 1982 [19]. f Cancers listed are incident cases. g NHANES I = First National Health and Nutrition Examination Survey. h Data on ST use were only collected in 3,847 subjects at baseline in 1971–1975, but were collected for all subjects in follow-up surveys in 1982–1984. 6,805 subjects were considered in the mortality analyses [21] and 7,779 in the incidence analyses [22]. i Numbers of cases not given. j CPS-I = Cancer Prevention Study I. k CPS-II = Cancer Prevention Study II. Some additional results for lung cancer, based on mortality to 2002, comparing 111,952 men who quit cigarette smoking with 4,443 who switched to ST, were presented by Henley et al. in 2007 [25]. l Results for chewing and snuff are also given for all cancers and lung cancers. m Some limited additional results, based on follow-up to 1978, were reported by Heuch et al. in 1983 [27] for pancreatic cancer incidence and in IARC Monograph 37 in 1985 [14] for cancers of the buccal cavity/pharynx, oesophagus, pancreas and prostate. n Cancers listed include incident cases. ° Includes cutaneous malignant melanoma, melanoma in situ and intraocular malignant melanoma. p Numbers are incident cases. An analysis of overall cancer based on 1,574 deaths was also conducted. ST = smokeless tobacco. |
||||||
|
Lee and Hamling BMC Medicine 2009 7:36 doi:10.1186/1741-7015-7-36 |
||||||